Bill · H.R. 5415· House(119-HR-5415)
Nitazene Control Act of 2025
- Introduced
- 9/16/2025
- Last activity
- 9/16/2025 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Sponsored by
- Eugene Vindman
- Cosponsors
- - 9 - 21
- Introduced
- In Committee
What this bill would do
The Nitazene Control Act of 2025 aims to amend the Controlled Substances Act to permanently schedule nitazenes. These benzimidazole-opioids are synthetic substances that can be more potent than fentanyl and contribute to fatal poisonings. The bill places these substances, including their various derivatives, into Schedule I. This action is intended to preemptively address the spread of new analogs and streamline enforcement. Additionally, the Act removes any temporary status for these substances, making them permanently scheduled upon enactment.
Yes· 3 of 4
Does this do more about addiction and overdose deaths?+7
The bill targets the proliferation of dangerous synthetic opioids to improve the national response to overdoses.
Would households on low incomes be better off under this?+2
The bill may provide public health benefits to vulnerable populations more frequently affected by the illicit drug supply.
Would people in cities be better off under this?+2
The bill targets substances that contribute to the rise of fatal poisonings in the illicit drug supply.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Public Health Protection: The bill aims to protect public health by addressing the proliferation of new nitazene analogs that contribute to overdoses and fatal poisonings (Section 2).
-
Streamlined Law Enforcement: A class-wide permanent scheduling is intended to streamline enforcement efforts regarding these substances (Section 2).
-
Preemptive Action: By scheduling the entire class of 2-benzylbenzimidazole opioids, the act seeks to preemptively address the emergence of new related compounds (Section 2).
Potential Negative Impacts for People
- Research Restrictions: The bill specifies that nothing in the act shall be construed to authorize the start of new research on these substances without proper registration and scheduling compliance (Section 3(c)).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Healthcare
- Improves Opioid Crisis Response+7
- Demographic And Interest Groups
- Good For Low Income Households+2Good For Urban Residents+2
- Social Issues And Justice
- Improves Policing Reform+2
- 5/11/2026
- 1 Cosponsor added.
- 4/22/2026
- 1 Cosponsor added.
- 4/15/2026
- 2 Cosponsors added.
- 3/3/2026
- 1 Cosponsor added.
- 2/20/2026
- 1 Cosponsor added.
- 2/13/2026
- 1 Cosponsor added.
- 2/10/2026
- 1 Cosponsor added.
- 1/13/2026
- 2 Cosponsors added.
- 1/12/2026
- 2 Cosponsors added.
- 1/7/2026
- 2 Cosponsors added.
- 12/19/2025
- 2 Cosponsors added.
- 12/18/2025
- 2 Cosponsors added.
- 12/16/2025
- 4 Cosponsors added.
- 12/10/2025
- 1 Cosponsor added.
- 11/28/2025
- 1 Cosponsor added.
- 11/19/2025
- 2 Cosponsors added.
- 11/18/2025
- 1 Cosponsor added.
- 11/7/2025
- 1 Cosponsor added.
- 10/24/2025
- 1 Cosponsor added.
- 9/16/2025
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 1 Cosponsor added.
- Introduced in House
James BairdRepublican · Indiana
Michael BaumgartnerRepublican · Washington
Robert BresnahanRepublican · Pennsylvania
Mike CareyRepublican · Ohio
Donald DavisDemocrat · North Carolina
Brian FitzpatrickRepublican · Pennsylvania
Russell FryRepublican · South Carolina
Randy FineRepublican · Florida
Daniel GoldmanDemocrat · New York
Brandon GillRepublican · Texas
Maggie GoodlanderDemocrat · New Hampshire
Andy HarrisRepublican · Maryland
Chrissy HoulahanDemocrat · Pennsylvania
Pat HarriganRepublican · North Carolina
Mike KellyRepublican · Pennsylvania
Susie LeeDemocrat · Nevada
Michael LawlerRepublican · New York
Sam LiccardoDemocrat · California
Richard McCormickRepublican · Georgia
Ryan MackenzieRepublican · Pennsylvania
Joe NeguseDemocrat · Colorado
Robert OnderRepublican · Missouri
August PflugerRepublican · Texas
Deborah RossDemocrat · North Carolina
Maria SalazarRepublican · Florida
Thomas SuozziDemocrat · New York
Derek SchmidtRepublican · Kansas
Glenn ThompsonRepublican · Pennsylvania
David TaylorRepublican · Ohio
Matt Van EppsRepublican · Tennessee